Oncotherm GmbH of Troisdorf at MEDICA 2018 in Düsseldorf -- MEDICA - World Forum for Medicine

Oncotherm GmbH

Belgische Allee 9, 53842 Troisdorf
Telephone +49 2241 31992-0
Fax +49 2241 31992-11

Hall map

MEDICA 2018 hall map (Hall 9): stand B11

Fairground map

MEDICA 2018 fairground map: Hall 9

Our range of products

Product categories

  • 01  Electromedical Equipment / Medical Technology
  • 01.04  Therapy and physical medicine
  • 01.04.02  Electro-therapy equipment

Electro-therapy equipment

  • 01  Electromedical Equipment / Medical Technology
  • 01.04  Therapy and physical medicine
  • 01.04.05  Thermotherapy systems
  • 01  Electromedical Equipment / Medical Technology
  • 01.04  Therapy and physical medicine
  • 01.04.07  Electromagnetic wave equipment, biofeedback systems

Electromagnetic wave equipment, biofeedback systems

  • 01  Electromedical Equipment / Medical Technology
  • 01.04  Therapy and physical medicine
  • 01.04.09  Other equipment for therapy and physical medicine

Other equipment for therapy and physical medicine

Our products

Product category: Thermotherapy systems

Our new, revolutionary loco-regional electro-hyperthermia device

EHY-2030 is our latest development in the treatment of loco-regional tumors. The newly designed device includes the Smart Electrode System (SES), the plug-in Patient Management System (PMS-100) and a user-friendly touch screen display with full system control. The new RF generator with increased power has been developed with a new intelligently controlled step motor tuning system for rapid impedance matching to achieve faster tuning times. The device is only for clinical use.

More Less

About us

Company details

Oncothermia, i. e. modulated-electro-hyperthermia for oncological use, is a fast developing supportive, complementary treatment method against different types of tumors. The principles are based on the classical method of Hyperthermia, but our aim, besides the absolute increase in temperature, is especially the direct electric-field energy absorption in the extracellular liquid and destroying the membrane of the cancer cells. Oncothermia’s effect is synergic to radiotherapy and to numerous chemotherapies. Furthermore, it leads to an increased immunogenicity and effectively reduces the pain of the patient.

Oncothermia in general is not used as a sole therapy. Usually it is combined with chemotherapy, radiotherapy or other therapies and their combination. The method transfers energy using the principle of capacitive coupling (like a condenser) of radio waves of 13,56 MHz. No external shielding is needed. Oncothermia utilizes the special absorption rate of the near-membrane extracellular liquid of the tumour. The tumor tissue has lower impedance than the surrounding tissues, so most of the energy is transmitted and absorbed by the cancerous lesion. This selection of the tumour tissues (self-focusing) renders external focusing unnecessary. 

Oncothermia achieves a permanent increase of the temperature in the extracellular liquid of the tumour tissue. Due to the constant energy-supply, a temperature gradient (temperature drop) between the extra- and intracellular electrolytes develops until the thermal equilibrium is reached at the end of the therapy. This (in absolute numbers very low) temperature difference acts on the likewise small distance through the cellular membrane (from extra- to intracellular) and that leads to a destabilizing thermal stress on the membrane of the tumour cells, leading those into necrosis or apoptosis.

More Less